Tag Archives: The Ohio State University Comprehensive Cancer Center

Prognostic and biologic significance of long noncoding RNA profiling in leukemia

lncRNA

Long non-coding ribonucleic acids (RNAs) are a novel class of RNA molecules, which are increasingly recognized as important molecular players in solid and hematologic malignancies. Herein, researchers from the Ohio State University Comprehensive Cancer Center investigated whether long non-coding RNA expression is associated with clinical and molecular features, as well as outcome of younger adults (aged <60 years) with de ...

Read More »

Long noncoding RNAs – A Novel Prognostic Marker In AML

lncRNA

From Drug Discovery News A new study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) describes a novel marker that might help doctors choose the least toxic, most effective treatment for many older patients with acute myeloid leukemia (AML). AML occurs mainly ...

Read More »